-transparent.png){kind=logo}
IgE was the last of the five immunoglobulin classes to be discovered and is the antibody that is responsible for much of human type I allergic disease. This review summarizes recent developments with respect to control of IgE synthesis with an emphasis on Th2 (T helper 2) control and regulation using IgE Fc receptors.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
January 1981,
Japanese journal of pharmacology,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
November 1986,
Immunology today,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
January 1982,
Progress in allergy,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
February 1987,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
January 1981,
International archives of allergy and applied immunology,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
January 1989,
International archives of allergy and applied immunology,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
January 1983,
Monographs in allergy,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
June 1981,
Federation proceedings,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
January 1988,
Annual review of immunology,
Daniel H Conrad, and
David R Gibb, and
Jamie Sturgill
November 1999,
Nature,
